Glory Health Industry Limited (2329.HK) HKSE
0.09
-0.01(-9.62%)
Currency In HKD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 506.98M |
| Enterprise Value | 24.19B |
| P/E Ratio | -0.2 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 0.35 |
| Price/Book Ratio | 0.04 |
| Enterprise/Revenue | 23.22 |
| Enterprise/EBITDA | -35.34 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
Profitability
| Profit Margin | -1.76 |
| Operating Margin | -0.74 |
Management Effectiveness
| Return On Assets | -0.03 |
| Return On Equity | -0.2 |
Income Statement
| Revenue | 1.04B |
| Revenue/Share | 0.23 |
| Gross Profit | -308.09M |
| EBITDA | -696.9M |
| Net Income | -1.82B |
| Diluted EPS | -0.41 |
Balance Sheet
| Total Cash | 138.18M |
| Total Cash/Share | 0.03 |
| Total Debt | 23.83B |
| Total Debt/Equity | 2.94 |
| Current Ratio | 0.68 |
| Book Value Per Share | 2.39 |
Price History
| 52-Week Change | 135 |
| 52-Week High | 0.22 |
| 52-Week Low | 0.04 |
| Moving Average 50 Days | 0.1 |
| Moving Average 200 Days | 0.13 |
Statistics
| Average Volume | 417,500 |
| Shares Outstanding | 4.44B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
